J
Jan Paul Ottervanger
Researcher at Brigham and Women's Hospital
Publications - 239
Citations - 8036
Jan Paul Ottervanger is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 41, co-authored 233 publications receiving 7285 citations.
Papers
More filters
Journal ArticleDOI
Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction Every Minute of Delay Counts
TL;DR: It is suggested that every minute of delay in primary angioplasty for STEMI affects 1-year mortality, even after adjustment for baseline characteristics, and all efforts should be made to shorten the total ischemic time.
Journal ArticleDOI
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
Arnoud W J van 't Hof,Jurriën M. ten Berg,Ton Heestermans,Thorsten Dill,Reinhard C. Funck,Wouter van Werkum,Jan-Henk E. Dambrink,Harry Suryapranata,Gert van Houwelingen,Jan Paul Ottervanger,Pieter R. Stella,Evangelos Giannitsis,Christian W. Hamm +12 more
TL;DR: The finding that routine prehospital initiation of high-bolus dose tirofiban improved ST-segment resolution and clinical outcome after PCI, emphasises that further platelet aggregation inhibition besides high-dose clopidogrel is mandated in patients with STEMI undergoing PCI.
Journal ArticleDOI
Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty Implications for Early Discharge
Giuseppe De Luca,Harry Suryapranata,Arnoud W J van 't Hof,Menko-Jan de Boer,Jan C.A. Hoorntje,Jan-Henk E. Dambrink,A T Marcel Gosselink,Jan Paul Ottervanger,Felix Zijlstra +8 more
TL;DR: This score is a practical and useful index for risk stratification after primary angioplasty for STEMI, with a significant impact on clinical decision-making and the related costs.
Journal ArticleDOI
Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.
Giuseppe De Luca,Arnoud W J van 't Hof,Menko-Jan de Boer,Jan Paul Ottervanger,Jan C.A. Hoorntje,A T Marcel Gosselink,Jan-Henk E. Dambrink,Felix Zijlstra,Harry Suryapranata +8 more
TL;DR: This study shows that in patients with STEMI treated by primary angioplasty prolonged ischaemic time is associated with impaired myocardial perfusion, larger infarct size, and higher 1-year mortality.
Journal ArticleDOI
Prognostic Value of Admission Glycosylated Hemoglobin and Glucose in Nondiabetic Patients With ST-Segment–Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention
Jorik R. Timmer,Miriam Hoekstra,Maarten W. N. Nijsten,Iwan C. C. van der Horst,Jan Paul Ottervanger,Robbert J. Slingerland,Jan-Henk E. Dambrink,Henk J. G. Bilo,Felix Zijlstra,Arnoud W J van 't Hof +9 more
TL;DR: In nondiabetic patients with ST-segment–elevation myocardial infarction, both elevated admission glucose and HbA1c levels were associated with adverse outcome, and measurement of both parameters enables identification of these high-risk groups for aggressive secondary risk prevention.